What is CRISPR Therapeutics AG's Market Cap?

CRISPR Therapeutics AG's Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Enterprise Value?

CRISPR Therapeutics AG's Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Price / Sales?

CRISPR Therapeutics AG's Price / Sales is 356.6×, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EV / Revenue?

CRISPR Therapeutics AG's EV / Revenue is 224.6×, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EV / EBITDA?

CRISPR Therapeutics AG's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Revenue (TTM)?

CRISPR Therapeutics AG's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Net Income (TTM)?

CRISPR Therapeutics AG's Net Income (TTM) is -$451.1M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EBITDA?

CRISPR Therapeutics AG's EBITDA is -$515.6M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Diluted EPS (TTM)?

CRISPR Therapeutics AG's Diluted EPS (TTM) is -4.67, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EBITDA Margin?

CRISPR Therapeutics AG's EBITDA Margin is -3850.4%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CRISPR Therapeutics AG

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00DBBGRY0

49.39▼ 0.60 (-1.20%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 49.99
Day's Range: 48.02 – 49.68
52-Week Range: 44.12 – 68.71
Volume: 2.1M
Avg Volume: 1.7M

Share Statistics

Shares Outstanding
Employees: 393
Exchange: XNAS
Listed: 2016-10-19

Share count as of July 31, 2026

CRISPR Therapeutics AG (CRSP) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about CRISPR Therapeutics AG (CRSP)

What is CRISPR Therapeutics AG's Market Cap?: CRISPR Therapeutics AG's Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Enterprise Value?: CRISPR Therapeutics AG's Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Price / Sales?: CRISPR Therapeutics AG's Price / Sales is 356.6×, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EV / Revenue?: CRISPR Therapeutics AG's EV / Revenue is 224.6×, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EV / EBITDA?: CRISPR Therapeutics AG's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Revenue (TTM)?: CRISPR Therapeutics AG's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Net Income (TTM)?: CRISPR Therapeutics AG's Net Income (TTM) is -$451.1M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EBITDA?: CRISPR Therapeutics AG's EBITDA is -$515.6M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Diluted EPS (TTM)?: CRISPR Therapeutics AG's Diluted EPS (TTM) is -4.67, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EBITDA Margin?: CRISPR Therapeutics AG's EBITDA Margin is -3850.4%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CRSPAs-filed SEC (XBRL) data